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Epithelial-mesenchymal transition (EMT) is an impor-
tant developmental process hijacked by cancer cells
for their dissemination. Here, we show that Exo70, a
component of the exocyst complex, undergoes iso-
form switching mediated by ESRP1, a pre-mRNA
splicing factor that regulates EMT. Expression of
the epithelial isoform of Exo70 affects the levels of
key EMT transcriptional regulators such as Snail
and ZEB2 and is sufficient to drive the transition to
epithelial phenotypes. Differential Exo70 isoform
expression in human tumors correlates with cancer
progression, and increased expression of the epi-
thelial isoform of Exo70 inhibits tumor metastasis
in mice. At the molecular level, the mesenchymal—
but not the epithelial—isoform of Exo70 interacts
with the Arp2/3 complex and stimulates actin poly-
merization for tumor invasion. Our findings provide
a mechanism by which the exocyst function and
actin dynamics are modulated for EMT and tumor
invasion.
INTRODUCTION
Epithelial-mesenchymal transition (EMT) is an important devel-
opmental process by which epithelial cells of apical-basolateral
polarity convert to migratory mesenchymal state (Yang and
Weinberg, 2008; Thiery et al., 2009). EMT is essential for embryo-
genesis and organ formation and is often hijacked by tumor cells
to achieve their efficient dissemination to distant organs (Nieto,
2011; Thiery et al., 2009; Valastyan and Weinberg, 2011; Yang
and Weinberg, 2008). Years of intensive research in the field
have demonstrated that transcriptional regulations involving
such factors as Snail, Twist, and ZEB1/2 are required for cancer
EMT (Huber et al., 2005; Thiery, 2002; Yang and Weinberg,
2008). Recently, accumulating evidence indicates that alterna-560 Developmental Cell 27, 560–573, December 9, 2013 ª2013 Elsevtive splicing also plays a significant role in EMT, with epithelial
and mesenchymal cells carrying distinct alternative splicing
signatures. ESRP1 and ESRP2 are key splicing factors that regu-
late the mesenchymal-to-epithelial transition (MET) and govern
the critical isoform switching events of a spectrum of genes
that are involved in intracellular signaling, cell-cell adhesion,
and cytoskeleton rearrangement (Dittmar et al., 2012; Shapiro
et al., 2011; Warzecha and Carstens, 2012; Warzecha et al.,
2009, 2010). However, how alternative splicing affects the
functions of protein isoforms to impact EMT or MET is poorly
understood.
The exocyst is an octameric protein complex consisting of
Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70, and Exo84
that are evolutionarily conserved from yeast to human. The exo-
cyst is essential for polarized exocytosis and plasma membrane
expansion (He and Guo, 2009; Hsu et al., 2004; Munson and
Novick, 2006). Recent studies have demonstrated that the exo-
cyst is involved in cell migration (Liu et al., 2009; Ren and Guo,
2012; Rosse´ et al., 2006; Spiczka and Yeaman, 2008; Thapa
et al., 2012; Zuo et al., 2006; Zhao et al., 2013). In particular,
the exocyst subunit Exo70 directly interacts with the Arp2/3
complex during cell migration (Liu and Guo, 2012; Liu et al.,
2009; Zuo et al., 2006). Besides cell migration, the exocyst is
also implicated in the establishment of epithelial apical-basolat-
eral asymmetry. Components of the exocyst were shown to be
recruited to adherens junctions, and disruption of the exocyst
function affected the formation of epithelia (Bryant et al., 2010;
Grindstaff et al., 1998; Yeaman et al., 2004). The establishment
of epithelial asymmetry and directional cell migration are thought
to be contrasting states that directly impact EMT. How the exo-
cyst paradoxically promotes these two seemingly opposite
cellular processes is intriguing.
In this study, we identify and characterize Exo70 as an
important splicing target of ESRP1. Interestingly, selective
expression of a single Exo70 isoform affects the expression
of transcription factors such as Snail and ZEB2 and leads to
cellular transitions between epithelial and mesenchymal pheno-
types. In humans, differential expression of Exo70 isoforms
correlates with breast tumor progression. At the molecular
level, Exo70 isoforms exhibit distinct abilities to interact withier Inc.
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Figure 1. ESRP1 Mediates the Alternative
Splicing of Exo70
(A) The mesenchymal (Exo70-M) and epithelial
(Exo70-E) isoforms of Exo70 are indicated.
Different exons in the variable region of Exo70 are
shown by different colors. Comparing Exo70-M
and Exo70-E, Exo70-E contains a 23-amino-acid
insertion that is part of Exon 8 generated by ESRP-
mediated alternative splicing.
(B and C) The expression of Exo70 isoforms
in MCF-7 (epithelial) and MDA-MB-231 cells
(mesenchymal) was examined by RT-PCR (B) and
western blot using an anti-Exo70 antibody that
recognizes both isoforms in the cell (C).
(D) RT-PCR analysis of Exo70 isoforms in MCF-7
cells treated with ESRP1 siRNA (left) or in MDA-
MB-231 cells overexpressing ESRP1 (right).
(E) Quantification of Exo70-M and Exo70-E mRNA
levels in cells used in (D). The expression levels of
Exo70 isoforms were normalized to GAPDH. n = 3.
*p < 0.05.
(F) ESRP1 expression levels in cells used in (D)
were examined by qPCR. Relative expression
levels of ESRP1were normalized toMCF-7 control
cells. n = 3. ***p < 0.001.
Student’s t test was performed using software R,
version 2.14. Error bars indicate SD. See also
Figure S1.
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The Role of Exo70 in EMT and Cancer Metastasisthe Arp2/3 complex and stimulate actin polymerization for cell
invasion. Our study not only reveals a role of Exo70 in EMT
but also demonstrates that specific expression of a splicing
isoform can be both a consequence and regulatory factor
during this critical transition. Our results suggest the interplays
among different regulatory paradigms (transcription and RNA
splicing) of EMT. Finally, our study indicates that alternative
splicing can be used to effectively switch the function of an
evolutionarily conserved protein for very different cellular
processes such as epithelial formation and mesenchymal
migration.
RESULTS
ESRP1 Mediates the Alternative Splicing of Exo70
Human cells have five Exo70 isoforms that differ in a region
located in the middle of the proteins. Using PCR primers flank-
ing the variable region, we examined the relative expression of
these 5 Exo70 isoforms in a number of human cell lines (Fig-
ure S1 available online). As the expression patterns of Exo70
isoforms 2 and 5 (henceforth referred to as ‘‘Exo70-M’’ and
‘‘Exo70-E,’’ respectively) (Figure 1A) consistently display a
correlation with the mesenchymal or epithelial phenotype,
they thereafter became the focus of our study. As shown in
Figure 1B, Exo70-E mRNA is highly expressed in the luminal
epithelial breast carcinoma cell line MCF-7 but not in theDevelopmental Cell 27, 560–573, Dclaudin-low, invasive breast cancer cell
line MDA-MB-231. This observation
was further confirmed by western blot
analysis with an anti-Exo70 monoclonal
antibody that recognizes both isoforms
of Exo70 (Figure 1C).Epithelial splicing regulatory proteins 1 and 2 (ESRP1 and
ESRP2) have recently been identified as important regulators
of EMT due to their role in orchestrating splicing events in a
wide range of proteins involved in cell adhesion and migration
(Warzecha et al., 2009, 2010). Exo70 was identified as one of
the top candidates that are spliced by ESRP1 and ESRP2 (War-
zecha et al., 2010). Here, we examined the regulation of Exo70
isoform expression by ESRP1 in epithelial and mesenchymal
cells (Figures 1D–1F). In MCF-7 cells, when ESRP1 expression
was silenced by siRNA, the level of Exo70-E was significantly
decreased. Conversely, in MDA-MB-231 cells, where the ex-
pression of endogenous ESRP1 level is low, ectopic expression
of ESRP1 led to an increase in Exo70-E expression.
Exo70 Isoform Switching during EMT
To examine the expression of Exo70 isoforms during EMT,
we used Twist1-ER-transfected human mammary epithelial
(HMLE) cells, a well-established inducible EMT model (Eckert
et al., 2011; Mani et al., 2008; Yang et al., 2004). Notably, during
14 days of EMT induction by tamoxifen (TAM), the level of
Exo70-E gradually diminished, whereas the level of Exo70-M
slightly increased as detected by RT-PCR (Figures 2A and 2B).
As positive controls, the downregulation of the epithelial marker
E-cadherin and upregulation of themesenchymal marker N-cad-
herin were observed along the time course of TAM treatment
(Figure 2A). Using quantitative PCR (qPCR), we found that theecember 9, 2013 ª2013 Elsevier Inc. 561
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Figure 2. Exo70 Isoform Switching during EMT
(A) RT-PCR analysis of mRNA levels of Exo70-E and Exo70-M during TAM-induced EMT in HMLE/Twist-ER cells. Specific primers that only amplified Exo70-E or
Exo70-M sequences were used. GAPDH was used as an internal control. The expression levels of E-cadherin and N-cadherin were examined by western blot,
which confirmed that the HMLE/Twist-ER cells had undergone EMT. b-actin was used as a protein loading control.
(B) Quantification of Exo70-M and Exo70-E mRNA levels in HMLE/Twist-ER cells used in (A). The expression levels of Exo70 isoforms in TAM-treated cells were
normalized to untreated cells.
(C) ESRP1 expression levels in HMLE/Twist-ER cells used in (A) were examined by qPCR. ESRP1 expression levels in TAM-treated cells were normalized to
untreated cells.
(D) RT-PCR analysis of Exo70-E and Exo70-M levels in HMLE/Twist-ER cells (TAM treated or untreated) overexpressing ESRP1. The expression levels of
E-cadherin and N-cadherin in these cells were examined by western blot. Cells transfected with vector alone were used as a negative control.
(E) Quantification of Exo70-M and Exo70-E mRNA levels in cells used in (D). The expression levels of Exo70 isoforms were normalized to TAM-untreated control
cell. *p < 0.05.
(F) ESRP1 expression levels in cells used in (D) were examined by qPCR. Relative expression levels of ESRP1 were normalized to untreated HMLE-control cells.
***p < 0.001.
(G) Phase-contrast images of ESRP1-induced morphological changes in HMLE-Twist cells after 14 days of TAM treatment. Scale bar, 75 mm.
(H) Alexa-488-phalloidin staining (green) showing ESRP1-induced actin cytoskeleton change in HMLE-Twist cells after 14 days of TAM treatment. Nuclei were
stained with DAPI (blue). Scale bar, 10 mm.
Student’s t test was performed using software R, version 2.14. Error bars indicate SD.
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The Role of Exo70 in EMT and Cancer Metastasisexpression of ESRP1 decreased correspondingly with Exo70-E
expression (Figure 2C). To test whether ESRP1 is involved in
the regulation of Exo70 isoform switching during EMT, we in-
fected HMLE/Twist1-ER cells with ESRP1, then treated these
cells with TAM. While the Exo70-E level in TAM-treated cells in-
fected with vector (as a control) had a much reduced level of562 Developmental Cell 27, 560–573, December 9, 2013 ª2013 ElsevExo70-E, cells infected with ESRP1 exhibited a high level of
Exo70-E expression (Figures 2D–2F). Furthermore, ESRP1
expression prevented TAM-induced HMLE/Twist-ER cells from
undergoing EMT, as indicated by the retention of the epithelial
marker E-cadherin, as well as blunted upregulation of the
mesenchymal marker N-cadherin compared with vector controlier Inc.
Developmental Cell
The Role of Exo70 in EMT and Cancer Metastasis(Figure 2D). Microscopy analyses showed that expression of
ESRP1 changed the cell morphology and actin organization
that happens during normal EMT (Figures 2G and 2H). Taken
together, these results suggest that ESRP-mediated Exo70 iso-
form switching takes place during EMT.
Expression of Exo70-E inMDA-MB-231 Cells Induces an
Epithelial Cell-like Phenotype
We next determined whether increased expression of Exo70-E
or Exo70-M could affect cell morphology. To this end, we gener-
ated MDA-MB-231 cell lines stably expressing green fluores-
cent protein (GFP)-tagged Exo70-E or Exo70-M. As shown in
Figure 3A, MDA-MB-231 cells expressing GFP-Exo70-M or
GFP vector alone retained dispersed and mesenchymal proper-
ties, with migratory leading edges indicated by actin staining. In
contrast, MDA-MB-231 cells expressing GFP-Exo70-E changed
from their original mesenchymal morphology to a cobblestone-
like epithelial morphology characterized by cell-cell adhesion
and compact cell clusters (Figure 3A; see also Figure 6E). As
MDA-MB-231 cells do not have detectable levels of E-/N-cad-
herin, but instead express cadherin-11 and b-catenin (Feltes
et al., 2002; Nieman et al., 1999), we examined b-catenin
localization by immunofluorescence microscopy. As shown in
Figure 3B and quantified in Figure S2A, b-catenin was distrib-
uted in the cytoplasm and nucleus in MDA-MB-231 cells
expressing GFP-Exo70-M or GFP. In cells expressing GFP-
Exo70-E, however, b-catenin was recruited to sites of cell-
cell contact along the entire cell periphery, suggesting that
Exo70-E is capable of inducing mesenchymal cells to acquire
epithelial-like properties.
Next, we examined the migration properties of MDA-MB-231
cells by wound healing assays (Figures 3C and 3D). We have
previously generated siRNA oligos that selectively knock
down Exo70 (Zuo et al., 2006; Liu et al., 2007, 2009). Here,
we found that cells with their endogenous Exo70 knocked
down by siRNA took more time for wound closure than control
cells. These cells, when expressing siRNA-resistant Exo70-M,
regained their migration velocity. In contrast, expression of
Exo70-E inhibited the migration of MDA-MB-231 cells. We
have also performed the transwell assay to examine the motility
of these cells. As shown in Figure 3E, while expression of
Exo70-E in Exo70 knockdown MDA-MB-231 cells failed to
rescue the motility defect, expression of Exo70-M promoted
cell motility. Our data suggest that the Exo70-M isoform is
involved in MDA-MD-231 cell migration, and the inhibitory
phenotype of Exo70-E probably results from its effect on epithe-
lial cell-like transition.
To investigate the impact of Exo70-M on epithelial cells, we
expressed GFP-Exo70-M in HMLE cells. As shown in Figures
3H and 3I, HMLE cells ectopically expressing Exo70-M tended
to lose the cell-cell junctions and appeared to bemore expanded
and dispersed. E-cadherin and b-catenin became less associ-
ated with the plasma membrane at the regions of cell-cell con-
tact. On the other hand, expression of GFP-Exo70-E or GFP
alone had no effect.
The observation that expression of a single Exo70 isoform led
to the transition between the epithelial andmesenchymal pheno-
types is striking. We therefore determined whether the expres-
sion of Exo70-E and Exo70-M affects the mRNA levels of theDevelopmkey EMT-inducing transcription factors, including Snail and
ZEB2 (Huber et al., 2005; Thiery, 2003). As shown in Figures
3F and 3G, while Exo70-M expression did not have marked
effects on the levels of Snail and ZEB2 in MDA-MD-231 cells,
Exo70-E expression led to a significant reduction of the mRNA
levels of both transcription factors. Furthermore, expression of
Exo70-E induced a significant upregulation of Snail and ZEB2
target genes (Figure S2B). This result suggests that Exo70-E,
though a splicing product of ESRP1, can in turn function as a
potential EMT and/or MET inducer.
Exo70-M, but Not Exo70-E, Promotes Tumor Cell
Invasion In Vitro
The EMT initiates tumor cell invasion, which leads to cancer
metastasis. We thus investigated the role of Exo70-E and
Exo70-M in tumor cell invasion. First, the invasiveness of
MDA-MB-231 cells was examined by transwell assays using
matrigel-coated Boyden chambers. Cells with their endogenous
Exo70 knocked down by siRNA were much less invasive (Fig-
ure 4A). When transfected with siRNA-resistant Exo70-M, these
cells regained their invasiveness. In contrast, expression of
Exo70-E failed to rescue the invasive property.
Invadopodia are cell membrane protrusions that extend to the
extracellular matrix (ECM). Invadopodia promote tumor cell inva-
sion and cancer metastasis by actin polymerization and degra-
dation of the ECM (Gimona et al., 2008; Linder, 2007; Murphy
and Courtneidge, 2011; Nu¨rnberg et al., 2011; Weaver, 2006;
Yamaguchi et al., 2005). We have investigated the role of
Exo70-E and Exo70-M in invadopodia activity by expressing
different Exo70 isoforms in c-Src Y527F-transfected MDA-MB-
231 cells (‘‘MDA-MB-231-Src’’) with siRNA knockdown of the
endogenous Exo70. The invadopodia activities of these cells
were examined by their ability to digest fluorescence-labeled
gelatin coated on the coverslips. As shown in Figures 4B and
4C, cells expressing Exo70-Mdisplayed a high level of invadopo-
dia activity. In contrast, cells expressing Exo70-E showed much
lower invadopodia activity that was even weaker than that of the
GFP control cells. Similar observations were made in MDA-MB-
231 cells without endogenous Exo70 knockdown (Figure S3A)
andMDA-MB-231 cells without Src overexpression (Figure S3B).
The exocyst complex is implicated in tumorigenesis, as its
Sec5 and Exo84 subunits are direct downstream effectors of
RalA and RalB, key components of the Ras signaling network
(Balakireva et al., 2006; Bodemann et al., 2011; Issaq et al.,
2010; Lim and Counter, 2005). We therefore also examined
whether the Exo70 isoforms differentially affect tumorigenesis.
Tumor cell proliferation was examined by generation of MDA-
MB-231 cells with stable expression of Exo70-E or Exo70-M
and measurement of the number of cells during 10 days of
culturing. Cells with different Exo70 isoforms exhibited a similar
growth rate (Figure 4E). Further examination of tumorigenesis by
soft agar colony assay also showed no difference among these
groups (Figure 4F). In fact, there is no detectable difference for
Exo70-E and Exo70-M to interact with other exocyst compo-
nents (discussed later). Our data suggest that Exo70-E and
Exo70-M differ in mediating tumor invasion. The isoform switch-
ing of Exo70 may thus specifically affect cell motility rather than
other aspects of exocyst function in cancer cells, including
tumorigenesis.ental Cell 27, 560–573, December 9, 2013 ª2013 Elsevier Inc. 563
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Figure 3. Expression of Specific Exo70 Isoforms Induces MET- or EMT-like Phenotypes
(A) Expression of Exo70-E in MDA-MB-231 cells induced epithelial-like cell phenotype. MDA-MB-231 cells stably expressing GFP-tagged Exo70-M or
Exo70-E were fixed and stained for F-actin (red) and nucleus (blue). Expression of Exo70-E led to epithelial-like cell clustering, whereas cells expressing Exo70-M
or GFP vector alone showed migratory phenotype as indicated by F-actin staining at the lamellipodia-like membrane expansions. At least three independent
clones of stable cell lines were tested. Representative images are shown here. The same applies to the following experiments using stable cell lines. Scale
bar, 10 mm
(B) Expression of GFP-Exo70-E, but not GFP-Exo70-M or GFP control, in MDA-MB-231 cells induced b-catenin relocalization to cell-cell contact sites. Scale
bar, 10 mm.
(C) Wound healing assay of indicated MDA-MB-231 cell lines. The cells were imaged at 0, 8, 24, and 48 hr after the wounds were made.
(D) Quantification of wound healing assay. TheMDA-MB-231 cells were imaged every 8 hr, and the time to complete wound closure was determined. n = 6. Three
independent clones of stable cell lines were tested. ***p < 0.001.
(E) Transwell assays of MDA-MB-231 cell migration. Cells were imaged and counted 12 hr after being seeded in the chamber. n = 3, three independent replicates.
*p < 0.05; ***p < 0.001.
(F and G) The mRNA levels of Snail (F) and ZEB2 (G) in MDA-MB-231 cells stably expressing GFP-tagged Exo70-M, Exo70-E, or GFP were detected by real-time
PCR. Relative expression levels of Snail or Zeb2 in the cells expressing Exo70-M or Exo70-E were normalized to GFP control cells. n = 3. *p < 0.05; **p < 0.01;
***p < 0.001; ns, no statistic significance.
(legend continued on next page)
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Figure 4. Different Effects of Exo70 Iso-
forms on Invadopodia-Dependent ECM
Degradation by MDA-MA-231 Cells
(A) Matrigel-transwell assays of MDA-MB-231
cell invasion. Cells with their endogenous
Exo70 knocked down by RNAi were defective
in invasion. Ectopic expression of Exo70-M
rescued the invasion defects in Exo70 knock-
down cells, whereas expression of Exo70-E
in the cells was unable to restore cell invasive-
ness. Student’s t test was performed using
software R, version 2.14. n = 3, three indepen-
dent replicates. **p < 0.01; ns, no statistic sig-
nificance.
(B) MDA-MB-231-Src cells with their endoge-
nous Exo70 knocked down by RNAi were
transfected with GFP or GFP-Exo70 isoforms
(green) and plated on coverslips coated with
Alexa 568-labeled gelatin (red) for 8 hr. F-actin
was detected by staining with Alexa-350-
phalloidin (blue). Invadopodia activity was de-
tected by the degradation of Alexa 568-labeled
gelatin (shown as black holes). Comparing cells
transfected with GFP alone, cells expressing
Exo70-E had much reduced level of invasion
(see cells with and without GFP-Exo70-E in
the same field). In contrast, cells expressing
Exo70-M had much increased levels of invasion.
Scale bar, 10 mm.
(C) Percentage of cells with different levels of
gelatin degradation was quantified. Three inde-
pendent experiments were performed for each
group, and 60 cells were counted for each group.
An ANOVA was performed using software R,
version 2.14. **p < 0.01; ***p < 0.001.
(D) The expression levels of GFP-Exo70 and
endogenous Exo70 in the above siRNA-treated cells were examined by western blot. siRNA against luciferase was used as a control. The levels of b-actin were
used as a loading control.
(E) Growth curves for Exo70-M and Exo70-E stable-expression cells. Cell numbers were counted every 2 days. ANOVAwas performed using software R, version
2.14. Three independent replicates were performed for each group. p > 0.5.
(F) MDA-MB-231 cells stably expressing GFP-Exo70-M or GFP-Exo70-E or GFP control were cultured in soft agar. Number of colonies in nine fields was counted
for each group. Student’s t test was performed using software R, version 2.14. Three independent replicates were performed for each group. No differences
among the three groups of cells were found.
Error bars indicate SD. See also Figure S3.
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The Role of Exo70 in EMT and Cancer MetastasisExpression of Different Exo70 Isoforms Does Not Affect
MMP Secretion but Affects Actin-Mediated Protrusion
during Invadopodia Formation
We next investigated the possible mechanisms that account for
the ability of different Exo70 isoforms in invadopodia activity.
First, we examined the exocytosis of matrix metalloproteinases
(MMPs) mediated by Exo70 isoforms as Exo70 is part of the
exocyst complex, which is known to regulate exocytosis, and
was previously shown to mediate the secretion of MMP2
and MMP9. The levels of MMP secretion in cells expressing
different Exo70 isoforms were compared by using the gelatin
degradation zymography. As shown in Figures 5A and 5B,
MDA-MB-231 cells with Exo70 knockdown had reduced levels
of MMP2 and MMP9 secretion in the media; expression of(H) Immunofluorescence staining of E-cadherin (red) shows that E-cadherin loca
Exo70-E but was diffuse in the cytoplasm in cells expressing GFP-Exo70-M (gre
(I) Immunofluorescence staining of b-catenin (red) shows their localization to the
expressing GFP-Exo70-M (green), b-catenin was less associated with the plasm
Student’s t test was performed using software R, version 2.14. Error bars indica
Developmeither Exo70-E or Exo70-M rescued MMPs secretion in a
similar fashion. Western blotting further confirmed that the
expression of each isoform was at a similar level. We also
compared the ability of Exo70-E and Exo70-M to interact with
other exocyst components by coprecipitating experiments.
MDA-MB-231 cells were transfected with glutathione S-trans-
ferase (GST)-tagged Exo70 isoforms, and then coprecipitation
of endogenous Sec8, another exocyst component, from cells
was examined. There was no difference in Sec8 binding to
the two Exo70 isoforms (Figure 5C). Together, our data suggest
that Exo70-E and Exo70-M do not differ in their ability to
mediate exocytosis.
In addition to MMP secretion, effective ECM degradation
by invadopodia at the invasion loci is also mediated by celllized to the plasma membrane in GFP control cells and cells expressing GFP-
en). Nuclei were stained with DAPI (blue). Scale bar, 10 mm.
cell-cell contacts in control cells and cells expressing GFP-Exo70-E. In cells
a membrane. Nuclei were stained with DAPI (blue). Scale bar, 10 mm.
te SD. See also Figure S2.
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Figure 5. Expression of Specific Exo70 Isoforms Has No Effect on MMP Secretion but Has Significant Effect on Invadopodia Formation in
MDA-MB-231 Cells
(A) In-gel zymography of MMP2 and MMP9 in MDA-MB-231 cells, MDA-MB-231 cells stably expressing siRNA-resistant GFP-Exo70-M or Exo70-E transfected
with Exo70 siRNA or control siRNA. Expression levels of endogenous Exo70, exogenous GFP-Exo70, and b-actin were detected by western blot.
(B) Quantification of MMP secretion from different groups of cells (n = 3).
(C) Equal amounts of Sec8 were coprecipitated with GST-tagged Exo70-M and Exo70-E from MDA-MB-231 cell lysates.
(D) MDA-MB-231-Src cells with their endogenous Exo70 knocked down by RNAi were transfected with GFP or GFP-Exo70 isoforms (green) and plated on
coverslips coated with 0.2% gelatin for 5 hr. Invadopodia were visualized by colocalization of cortactin (red) and F-actin (blue). Scale bar, 10 mm.
(E) Quantification of cells with invadopodia. Student’s t test was performed using software R, version 2.14. n = 50 cells per sample, three independent replicates.
**p < 0.01; ***p < 0.001.
Error bars indicate SD.
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The Role of Exo70 in EMT and Cancer Metastasisprotrusions generated by actin polymerization beneath the
plasma membrane (Pollard and Borisy, 2003; Ridley, 2011). It
was thought that actin activity marks the initial stage of invado-
podia formation, whereas MMP secretion occurs at the later
mature stage of invadopodia activity (Murphy and Courtneidge,
2011). Actin organization in invadopodia can be studied by fluo-
rescence localization of cortactin and F-actin (Bowden et al.,
2006; Clark et al., 2007; Eckert et al., 2011; Oser et al., 2009).
As shown in Figures 5D and 5E, while 52% of control MDA-
MB-231-Src cells showed costaining of cortactin and F-actin,
approximately 90% of cells exogenously expressing Exo70-M
exhibited colocalized cortactin with F-actin staining. In contrast,
cells exogenously expressing Exo70-E had reduced occurrence
of cortactin and F-actin costaining at a level below that of the
control cells. Taken together, our data suggest that Exo70-E
and Exo70-M differ in their ability to promote actin dynamics,
which contributes to their differences in invadopodia activities.566 Developmental Cell 27, 560–573, December 9, 2013 ª2013 ElsevExo70-M, but Not Exo70-E, Interacts with the Arp2/3
Complex and Stimulates Actin Branching
During cell invasion, the Arp2/3 complex generates a branched
actin network that ‘‘pushes’’ the plasma membrane at the lead-
ing edges for cell migration and invasion (Goley andWelch, 2006;
Insall and Machesky, 2009; Pollard and Borisy, 2003; Ridley,
2011). In invadopodia, the Arp2/3 complex plays an essential
role in protrusion formation (Gimona et al., 2008; Murphy and
Courtneidge, 2011; Nu¨rnberg et al., 2011; Weaver, 2006; Yama-
guchi et al., 2005). Having determined that the splicing of Exo70
isoforms did not affect MMP secretion, we next investigated
whether the Exo70 isoforms differentially affect the Arp2/3 com-
plex, as we had previously found that rat Exo70 can bind to the
Arpc1 subunit of Arp2/3 complex and is involved in invadopodia
formation (Liu et al., 2009; Ren and Guo, 2012; Zuo et al., 2006).
Using recombinant Exo70 and Arpc1, we found that a substan-
tially greater amount of Arpc1 bound to Exo70-M compared toier Inc.
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The Role of Exo70 in EMT and Cancer MetastasisExo70-E (Figure 6A). Similarly, in MDA-MB-231 cells expressing
GST-Exo70 and myc-Arpc1, Exo70-M, but not Exo70-E, bound
to Arpc1 (Figure 6B). Furthermore, Exo70-M was able to bind to
the purified Arp2/3 complex more strongly than Exo70-E (Fig-
ures S5F and S5G).
The Arp2/3 complex, upon activation by the N-WASP/WAVE
family of proteins, generates new actin filaments on the side of
preexisting filaments at a 70 angle. The in vitro generation of
actin branches can be monitored in real time using total internal
reflection fluorescence (TIRF) microscopy (Amann and Pollard,
2001a, 2001b). Here, we determined the effect of Exo70-E and
Exo70-M on the Arp2/3 complex-mediated actin branching
using dual-color time-lapse TIRF microscopy. Rhodamine-
labeled G-actin was polymerized for 3 min and immobilized on
aNEM-myosin-coated glass slide. Cy5-labeledG-actin with pro-
teinmixtures containing the purified Arp2/3 complex andWAVE2
together with purified Exo70-M or Exo70-E were flowed into the
chamber to replace the free rhodamine-labeled G-actin. The
generation of new filamentous actin was monitored over time.
As shown in Figure 6C, addition of Exo70-M substantially stimu-
lated actin branching mediated by the Arp2/3 complex and
WAVE2 (see also Movie S1 for better audio and visual presenta-
tions of the generations of nascent actin branches). On the other
hand, Exo70-E did not have a significant effect. Quantification of
actin branch generation (‘‘branching ratio’’: branches per preex-
isting actin filament) over time is shown in Figure 6D.
We have previously generated an Exo70-M mutant, Exo70-
M(D628-630), which is specifically defective in binding to the
Arp2/3 complex (Liu et al., 2012; Zuo et al., 2006). We found
that MDA-MB-231 cells expressing Exo70-M, but not Exo70-E
or Exo70-M(D628-630), show recruitment of the Arp2/3 complex
to the leading edge (Figure S4A). Furthermore, similar to
Exo70-E, stable expression of Exo70-M(D628-630) in MDA-
MB-231 cells induced a more epithelial-like morphology (Fig-
ure 6E). Expression of Exo70-M(D628-630) inMDA-MB-231 cells
with their endogenous Exo70 knocked down inhibited cell migra-
tion, cell invasion, and invadopodia formation in the transwell
assay and gelatin degradation assay (Figures 6F, 6G, S5A, and
S5B). Moreover, we found that expression of Exo70-M(D628-
630) failed to induce E-cadherin and b-catenin relocalization in
HMLE cells (Figures S4B and S4C). Interestingly, expression of
Exo70-M(D628-630) decreased expression of Snail and Zeb2
(Figure S5C), which is similar to the increased expression of
Exo70-E in cells. These data suggest that the capability of
Exo70-M to promote cell invasion rely on its interaction with
the Arp2/3 complex.
Exo70-E and Exo70-M Have Opposite Effects on Tumor
Metastasis in Mice
To determine whether the differences in Exo70 isoform expres-
sion at the cellular level are pathologically relevant, we sub-
cutaneously inoculated MDA-MB-231 cells stably expressing
different Exo70 isoforms in immunodeficientmice. Tumormetas-
tasis in thesemicewasmonitored over a period of 5weeks.While
tumor incidence was similar for each group (Figure 7A), Exo70-E
expression was found to efficiently suppress lung metastasis
(Figures 7B and 7C). The tumor tissues were also stained for cor-
tactin, which was used as a marker of dynamic actin activity
(Clark et al., 2007; Eckert et al., 2011; Oser et al., 2009). TumorDevelopmtissues expressing GFP-Exo70-E had a much lower level of cor-
tactin foci staining compared to those expressing GFP alone,
whereas tumor tissues expressing GFP-Exo70-M had a much
higher level of cortactin foci (Figures S6A and S6B).
Exo70 Isoforms Are Differentially Expressed in Human
Breast Tumors
The results presented earlier suggest a link between Exo70 iso-
form switching and tumor invasion and, thus, led us to test
whether the expression of these Exo70 isoforms correlates with
tumor progression in human tissue. Examination of Exo70-E
and Exo70-M splicing variant mRNA expression in human breast
tumor tissues revealed that the ratio of Exo70-E to Exo70-M (the
E/M ratio) was significantly lower in patients in which the tumor
had invaded the lymph nodes compared to samples in which
the tumor remained localized (p < 0.001; Figures 7D and 7E).
Furthermore, quantitative PCR (qPCR) analysis of the mRNA
levels of ESRP1 in the tumor samples demonstrated a positive
correlation between ESRP1 mRNA expression and E/M ratio
(p < 0.05; Figure 7F). These findings suggest that Exo70 isoform
switching is likely regulated by ESRP in breast tumor tissue.
DISCUSSION
While the role of transcriptional regulation in EMT has been well
established (Thiery et al., 2009; Yang et al., 2006), alternative
splicing has recently emerged as an important modulator of
EMT (Lapuk et al., 2010; Shapiro et al., 2011; Warzecha and
Carstens, 2012). ESRP1 and ESRP2 were identified as important
splicing factors (Dittmar et al., 2012;Warzecha et al., 2009, 2010)
that mediate the expression of different isoforms of proteins
such as FGFR2, p120 catenin, CD44, and Mena, that participate
in polarity establishment, adherens junction formation, and actin
cytoskeleton reorganization (Brown et al., 2011; Goswami et al.,
2009; Lipski et al., 2008; Ohkubo and Ozawa, 2004; Savagner
et al., 1994). The data presented in this study demonstrate that
the Exo70 subunit of the exocyst complex has splicing isoforms
that are differentially expressed during EMT. Expression of
Exo70-E in mesenchymal cells induced cell–cell contact and
attenuated cell motility, whereas expression of Exo70-M pro-
moted invadopodia formation and cell invasion. The current
study demonstrates that isoform switching of Exo70 plays an
important role in the transition between the epithelial andmesen-
chymal states.
ESRP1 and ESRP2 govern the pre-mRNA processing activ-
ities of an array of genes, and a loss of ESRP expression induces
some of the cellular changes that occur in EMT (Warzecha et al.,
2010), suggesting that global shifts in transcript variants may
potently drive EMT program. This is, to some extent, similar to
the global changes in gene expression levels induced by tran-
scription factors. For example, Snail has been reported to be
able to promote the splicing of p120 catenin, leading to
enhanced expression of mesenchymal p120 catenin isoform
(Ohkubo and Ozawa, 2004; Yanagisawa et al., 2008). These
data suggest that some cross-communication exists between
alternative splicing and transcriptional regulation. In the current
study, we found that increased expression of Exo70-E led to a
decrease of Snail and ZEB2 expression, which results in
transcriptional changes of their target genes and, therefore,ental Cell 27, 560–573, December 9, 2013 ª2013 Elsevier Inc. 567
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Figure 6. Exo70-M, but Not Exo70-E, Interacts with the Arp2/3 Complex and Stimulates Actin Branching
(A) In vitro binding of GST-Exo70-E and Exo70-M with Hisx6-Arpc1. GST-Exo70 isoforms were immobilized on glutathione-Sepharose and then incubated with
1 mg, 3 mg, or 10 mg of Hisx6-Arpc1, respectively. Input and bound Hisx6-Arpc1 were analyzed by western blot with anti-Hisx6 antibody. GST and GST-tagged
Exo70 isoforms are stained with Coomassie blue. GST-Exo70-M showed strong dose-dependent interactions with Hisx6-Arpc1.
(B) The binding of Exo70-M and Arpc1 in cells. GST-Exo70-E, GST-Exo70-M, and GST were cotransfected with Myc-Arpc1 into MDA-MB-231 cells. Arpc1
coprecipitated with Exo70-M but not Exo70-E.
(C) Exo70-M, but not Exo70-E, stimulated the Arp2/3 complex-mediated actin branching as observed by dual-color time-lapse TIRF microscopy. After 2 mM of
6% rhodamine-labeled G-actin (green) had been allowed to polymerize in the flow chamber for 3 min, 0.8 mM of 8% Cy5-labeled actin (red) with all the proteins
was loaded into the chamber to replace the rhodamine-labeled actin. Frames are shown at 0, 100, 200, and 400 s after the Cy5-G-actin and protein mixture had
been loaded. The newly generated branches are indicated by white dots.
(D) Quantification of actin branching over time. Branching ratio was defined as the number of branches divided by the number of total actin filaments in the same
field. n = 3. **p < 0.01; ***p < 0.001.
(E) Expression of Exo70-M(D628-630) in MDA-MB-231 cells induced epithelia-like morphology. Scale bar, 50 mm.
(legend continued on next page)
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Figure 7. Different Effects of Exo70 Isoforms on Tumor Metastasis
(A) Tumor incidence 5 weeks after introducing MDA-MB-231 cells stably expressing Exo70-E, Exo70-M, or GFP to immunodeficient mice.
(B) Representative images of hematoxylin and eosin staining of mice lung sections.
(C) Percentage of mice with lung tumors among the three different groups of mice.
(D) RT-PCR analysis of Exo70-E and Exo70-M expression in patient breast tumors. The left panel shows tumor samples collected from patients with localized
breast tumors. The right panel shows tumor samples collected from patients with breast tumors invaded to lymph nodes. Note that the total amounts of RNA
collected from these clinical samples were different as indicated by GAPDH levels.
(E) The Exo70-E to Exo70-M ratio of each sample in (D) is calculated with ImageJ software. ***p < 0.001. ANOVA was performed using software R, version 2.14.
(F) Ratio of Exo70-E to Exo70-M mRNA level (the E/M ratio) in each tumor sample plotted against the corresponding ESRP1 mRNA level in the same sample.
Linear regression analysis was performed using software R, version 2.14; p < 0.05.
See also Figure S6.
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The Role of Exo70 in EMT and Cancer Metastasisattenuation of EMT. This result raises the possibility that targets
of ESRP splicing also, in turn, modulate the transcription pro-
gram of EMT, thus adding another layer of complexity to the
regulatory network of EMT. Future biochemical and cell
biological analyses, together with multifactor simulation using
systems biology, may help elucidate the interplays among these
regulatory paradigms.
From the perspective of cell morphology, a shift from the
apical-basolateral polarity to ‘‘front-rear’’ polarity takes place
during EMT. The exocyst complex has been localized to adhe-
rens junctions and mediates the establishment of epithelial
polarity (Grindstaff et al., 1998; Nelson, 2003; Yeaman et al.,
2004). In addition, the exocyst has been observed to mediate
the incorporation of E-cadherin to the plasma membrane for
the establishment and maintenance of cell-cell junction (Lange-
vin et al., 2005; Leibfried et al., 2008). Therefore, the exocyst(F) Transwell assay of MDA-MB-231 cells with their endogenous Exo70 knocke
M(D628-630) was unable to rescue the migration defects in Exo70 knockdown c
(G) Matrigel-transwell assay shows that MDA-MB-231 cells with their endogenou
of Exo70-M(D628-630) was unable to rescue the invasion defects in Exo70 knoc
Student’s t test was performed using software R, version 2.14. Error bars indica
Developmplays an important role in epithelial polarity. On the other hand,
the exocyst, especially the Exo70 subunit, has also been shown
tomediate directional cell migration (Letinic et al., 2009; Liu et al.,
2009; Rosse et al., 2009; Rosse´ et al., 2006; Thapa et al., 2012;
Zuo et al., 2006). Here, we show that Exo70-M, but not Exo70-E,
interacts with, and kinetically stimulates, the Arp2/3 complex to
promote branched actin network formation, which is essential
for the generation of membrane protrusions such as invado-
podia. Our work thus provides a possible mechanism for the
observed switch in cellular phenotypes. It also demonstrates
that alternative splicing of an evolutionarily conserved ‘‘house-
keeping’’ gene can account for two seemingly paradoxical
behaviors. Exo70-E differs from Exo70-M by a 23-amino-acid
insertion conferred by ESRP splicing. It is possible that this inser-
tion leads to conformational changes of the Exo70 protein that
negatively affect its interaction with the Arp2/3 complex. It isd down by RNAi were defective in migration. Ectopic expression of Exo70-
ells. n = 3. **p < 0.01; ***p < 0.001.
s Exo70 knocked down by RNAi were defective in invasion. Ectopic expression
kdown cells. n = 3. ***p < 0.001; ns, no statistical significance.
te SD. See also Figures S4, S5, and Movie S1.
ental Cell 27, 560–573, December 9, 2013 ª2013 Elsevier Inc. 569
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The Role of Exo70 in EMT and Cancer Metastasisinteresting to note that land plants have around 20 Exo70 paral-
ogs per genome; this diversification during evolution is thought
to be related to the diverse structures of the endomembranes
and surface domains observed in land plants and their competi-
tion with parasites (Cvrckova´ et al., 2012; Za´rsky´ et al., 2009).
In addition to tumor invasion, the exocyst complex has previ-
ously been demonstrated to play a role in tumorigenesis. Two of
the exocyst subunits, Sec5 and Exo84, directly interact with the
guanosine triphosphate (GTP)-bound form of RalA and RalB,
which are components of the Ras signaling pathway (Balakireva
et al., 2006; Bodemann et al., 2011; Camonis and White, 2005;
Feig, 2003; Issaq et al., 2010; Lim and Counter, 2005; Moska-
lenko et al., 2002; Moskalenko et al., 2003; Polzin et al., 2002).
The Ral-exocyst interaction is required for the subsequent acti-
vation of oncogenic kinases such as TBK1 (Balakireva et al.,
2006; Bodemann et al., 2011). Our data suggest that different
Exo70 isoforms have the same interactions with the other exo-
cyst components. The isoform switching of Exo70 does not
affect the function of the exocyst complex in exocytosis and
oncogenesis but rather serves as a regulatory mechanism that
controls EMT and tumor metastasis. Together, these studies
suggest that the exocyst complex is implicated in several key
stages of cancer and may provide a link between tumorigenesis
and cancer dissemination. Future studies of Exo70 and the exo-
cyst complex may hold exciting potentials for diagnosis and
therapeutics of cancer.
EXPERIMENTAL PROCEDURES
Plasmids and antibodies, RNA extraction, RT-PCR, real-time PCR, and immu-
nofluorescence assay are described in the Supplemental Experimental
Procedures.
Cell Culture and Transfection
The study protocol that uses human cells was approved by the institutional re-
view board of the University of Pennsylvania. MDA-MB-231 and MCF7 cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen)
supplemented with 10% fetal bovine serum (FBS), 2 mM of L-glutamine,
100 U/ml of penicillin, and 100 of mg/ml streptomycin. Maintenance of the
immortalized HMLE and HMLE/Twist-ER cells was performed as described
(Yang et al., 2004). DNA transfection into cells was conducted using
LipofectAMINE 2000 (Invitrogen) or Fugene 6 (Roche), and RNA transfection
into cells was conducted using LipofectAMINE RNAiMAX (Invitrogen). The
Human Exo70 siRNA target sequence was 50- GGTTAAAGGTGACTGATTA-30
and the control Luciferase GL2 siRNA target sequencewas 50- AACGTACGCG
GAATACTTCGA-30. Cells were harvested 48 hr after transfection.
Stable MDA-MB-231 cell lines expressing GFP, GFP-Exo70-E, and GFP-
Exo70-M were selected using G418 (1 mg/ml). Single positive colonies were
selected by fluorescence-activated cell sorting (FACS; Flow Cytometry and
Cell Sorting Resource Laboratory, University of Pennsylvania). Colonies
were maintained in DMEM for 2 weeks, and multiple clones were isolated
and used for subsequent experiments. Expression levels were determined
by fluorescence microscopy and western blotting. Cluster formation was
observed in MDA-MB-231 cells by seeding them at 2 3 103 cells per well in
a six-well dish. Cells were maintained in DMEM for 1–2 weeks before
microscopy.
Binding Experiments
For Hisx6-Arpc1 and GST-Exo70 binding assay, Hisx6-Arpc1 and GST-Exo70
were purified from bacteria. A total of 5 mg of GST-Exo70-E or GST-Exo70-M
and 1 mg, 3 mg, or 10 mg of His-Arpc1 were diluted in 0.6 ml of binding buffer
(20 mM of HEPES, pH 7.4; 1 mM of EDTA; 150 mM of NaCl; 1% Triton
X-100; 1 mM of dithiothreitol (DTT); and protease inhibitors cocktail), and
mixed with 30 ml (50% v/v) of glutathione Sepharose-4B. After overnight incu-570 Developmental Cell 27, 560–573, December 9, 2013 ª2013 Elsevbation at 4C, beads were washed five times with the same binding buffer, and
the bound proteins were analyzed by western blotting.
To detect the interaction of Arpc1 with Exo70 in cells, MDA-MB-231 cells
were cotransfected with Myc-Arpc1 and GST-Exo70-E, GST-Exo70-M, or
GST vector. Cells were harvested at 72 hr posttransfection and lysed in the
lysis buffer (20 mM of HEPES, pH 7.4; 1 mM of EDTA; 150 mM of NaCl;
0.5% Triton X-100; 1 mM of DTT, and protease inhibitors). After cell lysates
were incubated overnight with glutathione Sepharose-4B at 4C, the beads
were washed five times with the lysis buffer, and the bound proteins were
analyzed by western blotting using an anti-Myc monoclonal antibody.
To examine the interaction between the Exo70 isoforms and the Arp2/3
complex, we purified GST-Exo70 isoforms from bacteria. The GST tag on
Exo70 isoforms were removed by PreScission Protease. Arp2/3 complex
was purified as described previously (Liu et al., 2012). For the binding reaction,
1 mg Exo70, 1 mg GST-CA protein, and 5 mg of Arp2/3 complex were diluted in
0.6 ml of binding buffer, described earlier, and mixed with 20 ml (50% v/v) of
glutathione Sepharose-4B beads. After overnight incubation at 4C, the beads
were washed five times with the same binding buffer, and the bound proteins
were analyzed by western blotting.
Wound Healing Assay and Transwell Assay
For wound healing assay, cells were cultured to confluence on 6-well plates,
and a scratch was made using a pipette tip. Cells were washed with PBS to
remove the detached cells and the remaining cells were incubated with regular
medium and observed every 8 hr until the time point of complete wound
closure. Assays were repeated three times for each clone.
The transwell migration assay was performed by seeding 13 105 MDA-MB-
231 cells that had undergone different treatments to the upper chamber of
transwell inserts (6.5 mm in diameter with 8.0-mm pores, Corning). Serum-
free DMEM was added to the cells in the upper chamber and 700 ml of
DMEM containing 10% FBS to the lower chamber. After 12 hr of incubation,
the inserts were washed with PBS, and the migrated cells on the lower side
of the membrane were fixed and stained with Giemsa stain. The number of
cells was counted in three randomly chosen fields per transwell insert. For
the Matrigel-transwell assay, the procedure was similar with the transwell
migration assay, except that the transwell membranes were precoated with
40 ng of Matrigel (BD Biosciences), and the cells were incubated for 24 hr.
Soft Agar Assay for Colony Formation
MDA-MB-231 cells stably expressing GFP, GFP-Exo70-E, or Exo70-M were
seeded in six-well plates at a density of 500 cells per well. Each well contained
1 ml of 0.7% soft agar in complete DMEM as the bottom layer and 1 ml of
0.38% agar in complete DMEM as the feeder layer. After 3 weeks of incuba-
tion, the number of colonies was determined under microscopy at 1003
magnification, with three independent wells examined for each group.
Monitoring Actin Branching using TIRF Microscopy
TIRF microscopy analysis of actin branching was performed as described
previously (Amann and Pollard, 2001b). Briefly, after glass coverslips and
Dow Corning 732 multipurpose silicone sealant had been used to prepare
chambers, 50 nM of N-ethyl maleimide (NEM)-myosin in high salt buffer
(500 mM of KCl) was used to immobilize actin filaments and 1% BSA was
used to block nonspecific binding to the surface. Proteins were mixed in the
actin polymerization buffer (60 mM of KC1; 2.5 mM of NaCl; 0.6 mM of
MgCl2; 5 mM of Tris-HCl, pH 7.5; 2.5 mM of HEPES, pH 7.1; 0.5 mM of
EGTA; 30 mM of CaCl2; 0.2 mM of ATP; and 0.3 mM of NaN3) and incubated
for 30 min at 4C. After 2 mM of Mg2+-G-actin (6% rhodamine labeled) in poly-
merization buffer had been loaded into the flow chamber and allowed to poly-
merize for 3min, it was replaced with 0.8 mMofMg2+-G-actin (8%Cy5 labeled)
and a protein mixture (15 nM of Arp2/3 complex, 25 nM ofWAVE2, and 250 nM
of Exo70-M or Exo70-E) in polymerization buffer. Immediately after the addi-
tion of Cy5-labeled actin, the chamber was imaged every 2 s by TIRF micro-
scopy for 10 min (Nikon TE2000U inverted microscope with an in-house
TIRF illuminator).
In-Gel Zymography
In-gel zymography assay was performed for detection of MMP secretion as
described previously (Liu et al., 2009). After cells had been cultured inier Inc.
Developmental Cell
The Role of Exo70 in EMT and Cancer Metastasisserum-free DMEM for 24 hr, the media were collected and concentrated.
Samples were then separated on 8% polyacrylamide/0.3% gelatin gel.
Following electrophoresis, the gel was washed twice in 2.5% Triton X-100
and incubated in reaction buffer (50 mM of Tris-HCl, pH 8.0, and 5 mM of
CaCl2) at 37
C for 24 to 48 hr. After the reaction, the gel was stained with stain-
ing buffer (0.12% Coomassie blue R-250, 50% methanol, and 20% acetic
acid) for 1 hr and destained overnight with destaining buffer (22% methanol
and 10% acetic acid). Gel loading values were normalized to total protein
measured using a Bio-Rad Protein Assay Kit, with measurement of each
sample repeated three times.
In Situ Zymography
The protocol used to perform in situ zymography was adapted from the
Mueller Laboratory (Artym et al., 2009). In brief, Alexa Fluor 568-conjugated
gelatin was prepared by Alexa Fluor 568 protein labeling (Molecular Probes)
according to the manufacturer’s instructions. After 18-mm coverslips had
been incubated in 20% nitric acid for 30 min and washed with water, they
were incubated with 50 mg/ml of poly-L-lysine (Sigma) for 20 min, fixed with
0.5% glutaraldehyde (Ted Pella) for 15 min, and washed with PBS. The
coverslips were then inverted onto 60-ml droplets of gelatin matrix (0.2%
gelatin and Alexa Fluor 568-labeled gelatin at an 8:1 ratio) for 10 min, washed
in PBS, and incubated in 5 mg/ml of NaBH4 for 15 min. After the coverslips
had been washed in PBS and incubated in DMEM for 2 hr, 2 3 104 cells
were seeded on to the coverslips and incubated at 37C for 8 hr, and then
processed for immunofluorescence. Each experiment was repeated three
times. Gelatin degradation was quantified using ImageJ software, with the
degradation level of each cell measured as the area of the degraded
zones per cell relative to the area of the entire cell. For quantification of gel
degradation, the percentage of cells with different degradation levels was
calculated.
Xenograft Tumor Model
A xenograft tumor model was created by subcutaneous injection of MDA-
MB-231 cells (2 3 106 cells per animal) stably expressing GFP, Exo70-E, or
Exo70-M into 8, 8, and 15, respectively, 4- to 5-week-old female athymic
nu/nu mice. Tumors were palpable at approximately 1 week, and caliper mea-
surements were obtained twice per week. Mice were sacrificed after 5 weeks.
Lungs were harvested and embedded in paraffin, sectioned, stained with
hematoxylin and eosin, and then imaged. Lungs with tumor were identified
as an indicator ofmetastasis. Mice with lung tumor were counted and statistics
analysis (Fisher’s exact test) was performed. The animal research was
approved by the Institutional Animal Care andUseCommittee at the University
of Pennsylvania.
Statistical Analyses
All statistical analyses (Student’s t test, ANOVA, and linear regression analysis)
were performed using software R, version 2.14.
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